Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Abstract 2032: Intratumoral tumor infiltrating lymphocytes is associated with cell proliferation and better survival but not with response to chemotherapy

Rongrong Wu, Masanori Oshi, Mariko Asaoka, Masayuki Nagahashi, Li Yan, Yasuo Miyoshi, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2023) 83 (7_Supplement): 2032.

https://doi.org/10.1158/1538-7445.AM2023-2032

Published: 04 April 2023

View article titled, Abstract 2032: Intratumoral tumor infiltrating lymphocytes is associated with cell proliferation and better survival but not with response to chemotherapy

Journal Articles

Abstract 1408: Increased infiltrating class-switched memory B cell in breast cancer tumors were associated with favorable prognostic outcome

Mariko Asaoka, Rongrong Wu, Takashi Ishikawa

Cancer Res (2023) 83 (7_Supplement): 1408.

https://doi.org/10.1158/1538-7445.AM2023-1408

Published: 04 April 2023

View article titled, Abstract 1408: Increased infiltrating class-switched memory B cell in breast cancer tumors were associated with favorable prognostic outcome

Journal Articles

Abstract PD2-10: MiR-150 expression in breast cancer cells attract infiltration of lymphocytes to tumor microenvironment and is associated with better survival of the patients

Masanori Oshi, Aparna Maiti, Raj.G Vaghjiani, Rongrong Wu, Li Yan, Akimitsu Yamada, Nitai Hait, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe, Yoshihisa Tokumaru

Cancer Res (2023) 83 (5_Supplement): PD2-10.

https://doi.org/10.1158/1538-7445.SABCS22-PD2-10

Published: 01 March 2023

View article titled, Abstract PD2-10: MiR-150 expression in breast cancer cells attract infiltration of lymphocytes to tumor microenvironment and is associated with better survival of the patients

Journal Articles

Abstract P2-20-12: Abundance of tumor-infiltrating lymphocytes is associated with pathologic complete response to neoadjuvant chemotherapy but not with survival in ER-positive/HER2-negative breast cancer

Rongrong Wu, Masayuki Nagahashi, Masanori Oshi, Yasuo Miyoshi, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2023) 83 (5_Supplement): P2-20-12.

https://doi.org/10.1158/1538-7445.SABCS22-P2-20-12

Published: 01 March 2023

View article titled, Abstract P2-20-12: Abundance of tumor-infiltrating lymphocytes is associated with pathologic complete response to neoadjuvant chemotherapy but not with survival in ER-positive/HER2-negative breast cancer

Journal Articles

Abstract P3-05-33: High expression of MiR-99b in breast cancer is associated with cell proliferation signaling and worse patient survivals in breast cancer

Masanori Oshi, Yoshihisa Tokumaru, Nobuhiko Sugito, Mahato Sasamoto, Rongrong Wu, Li Yan, Akimitsu Yamada, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Cancer Res (2023) 83 (5_Supplement): P3-05-33.

https://doi.org/10.1158/1538-7445.SABCS22-P3-05-33

Published: 01 March 2023

View article titled, Abstract P3-05-33: High expression of MiR-99b in breast cancer is associated with cell proliferation signaling and worse patient survivals in breast cancer

Journal Articles

Abstract P2-23-13: Highly proliferative estrogen receptor-positive breast cancer is associated with better response to neoadjuvant chemotherapy but worse clinical outcome

Rongrong Wu, Yoshihisa Tokumaru, Mariko Asaoka, Masanori Oshi, Li yan, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2023) 83 (5_Supplement): P2-23-13.

https://doi.org/10.1158/1538-7445.SABCS22-P2-23-13

Published: 01 March 2023

View article titled, Abstract P2-23-13: Highly proliferative estrogen receptor-positive breast cancer is associated with better response to neoadjuvant chemotherapy but worse clinical outcome

Journal Articles

Abstract 812: High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer

Rongrong Wu, Ankit Patel, Yoshihisa Tokumaru, Mariko Asaoka, Masanori Oshi, Li Yan, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2022) 82 (12_Supplement): 812.

https://doi.org/10.1158/1538-7445.AM2022-812

Published: 15 June 2022

View article titled, Abstract 812: High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer

Journal Articles

Abstract 3061: Elevated bile acid metabolism is associated with breast cancer microbiome, less cell proliferation, and better survival

Rongrong Wu, Quratulain Sabih, Masanori Oshi, Takashi Ishikawa, Li Yan, Kazuaki Takabe

Cancer Res (2022) 82 (12_Supplement): 3061.

https://doi.org/10.1158/1538-7445.AM2022-3061

Published: 15 June 2022

View article titled, Abstract 3061: Elevated bile acid metabolism is associated with breast cancer microbiome, less cell proliferation, and better survival

Journal Articles

Abstract 5663: Clinical relevance of unfolded protein response (UPR) signaling in breast cancer

Masanori Oshi, Shipra Gandhi, Rongrong Wu, Akimitsu Yamada, Li Yan, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Cancer Res (2022) 82 (12_Supplement): 5663.

https://doi.org/10.1158/1538-7445.AM2022-5663

Published: 15 June 2022

View article titled, Abstract 5663: Clinical relevance of unfolded protein response (UPR) signaling in breast cancer

Journal Articles

Abstract P3-10-01: Mir-150 expression is associated with immune cell infiltration and immune response in breast cancer

Masanori Oshi, Shipra Gandhi, Rongrong Wu, Li Yan, Akimitsu Yamada, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P3-10-01.

https://doi.org/10.1158/1538-7445.SABCS21-P3-10-01

Published: 15 February 2022

View article titled, Abstract P3-10-01: Mir-150 expression is associated with immune cell infiltration and immune response in breast cancer

Journal Articles

Abstract P1-01-15: Clinical relevance of TRIM37 gene expression in breast cancer

Junko Tsuchida, Rongrong Wu, Maiko Endo, Kazuki Moro, Chie Toshikawa, Yu Koyama, Hiroshi Ichikawa, Takaaki Hanyu, Yamato Takabe, Kazuyasu Takizawa, Yoshifumi Shimada, Takashi Kobayashi, Takashi Ishikawa, Jun Sakata, Toshifumi Wakai, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P1-01-15.

https://doi.org/10.1158/1538-7445.SABCS21-P1-01-15

Published: 15 February 2022

View article titled, Abstract P1-01-15: Clinical relevance of TRIM37 gene expression in breast cancer

Journal Articles

Abstract P1-05-06: Establishment of novel BRCA1ness score to quantify BRCAness in breast cancer

Masanori Oshi, Rongrong Wu, Akimitsu Yamada, Li Yan, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P1-05-06.

https://doi.org/10.1158/1538-7445.SABCS21-P1-05-06

Published: 15 February 2022

View article titled, Abstract P1-05-06: Establishment of novel BRCA1ness score to quantify BRCAness in breast cancer

Journal Articles

Abstract P3-19-27: Prognostic impact of postmastectomy radiation therapy in breast cancer patients with T1, 2 and 1-3 lymph nodes from Japan Breast Cancer Registry

Akimitsu Yamada, Naoki Hayashi, Hiraku Kumamaru, Masayuki Nagahashi, Shiori Usune, Hiroaki Miyata, Takashi Ishikawa, Kazutaka Narui, Itaru Endo, Shigeru Imoto, Shinji Ohno, Hiromitsu Jinno

Cancer Res (2022) 82 (4_Supplement): P3-19-27.

https://doi.org/10.1158/1538-7445.SABCS21-P3-19-27

Published: 15 February 2022

View article titled, Abstract P3-19-27: Prognostic impact of postmastectomy radiation therapy in breast cancer patients with T1, 2 and 1-3 lymph nodes from Japan Breast Cancer Registry

Journal Articles

Abstract P4-04-04: APOBEC3F is expressed by immune cells and is associated with immune response and survival in triple negative breast cancer

Rongrong Wu, Masanori Oshi, Mariko Asaoka, Akimitsu Yamada, Li Yan, Itaru Endo, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P4-04-04.

https://doi.org/10.1158/1538-7445.SABCS21-P4-04-04

Published: 15 February 2022

View article titled, Abstract P4-04-04: APOBEC3F is expressed by immune cells and is associated with immune response and survival in triple negative breast cancer

Journal Articles

Abstract P4-07-29: Reactive Oxygen Species (ROS) pathway is associated with aggressive cancer biology, elevated immune response, and with worse survival in ER-positive/HER2-negative breast cancer

Masanori Oshi, Rongrong Wu, Akimitsu Yamada, Li Yan, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P4-07-29.

https://doi.org/10.1158/1538-7445.SABCS21-P4-07-29

Published: 15 February 2022

View article titled, Abstract P4-07-29: Reactive Oxygen Species (ROS) pathway is associated with aggressive cancer biology, elevated immune response, and with worse survival in ER-positive/HER2-negative breast cancer

Journal Articles

Abstract P5-06-03: Intratumoral lymphatic endothelial cell infiltration reflects lymphangiogenesis and lymph node metastasis, but is counterbalanced by immune response and better cancer biology in breast cancer tumor microenvironment

Rongrong Wu, Masanori Oshi, Mariko Asaoka, Akimitsu Yamada, Yamato Takabe, Li Yan, Itaru Endo, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P5-06-03.

https://doi.org/10.1158/1538-7445.SABCS21-P5-06-03

Published: 15 February 2022

View article titled, Abstract P5-06-03: Intratumoral lymphatic endothelial cell infiltration reflects lymphangiogenesis and lymph node metastasis, but is counterbalanced by immune response and better cancer biology in breast cancer tumor microenvironment

Journal Articles

Abstract P5-03-01: Conflicting roles of EGFR expression by subtypes in breast cancer

Masanori Oshi, Shipra Gandhi, Yoshihisa Tokumaru, Rongrong Wu, Li Yan, Akimitsu Yamada, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P5-03-01.

https://doi.org/10.1158/1538-7445.SABCS21-P5-03-01

Published: 15 February 2022

View article titled, Abstract P5-03-01: Conflicting roles of <em>EGFR</em> expression by subtypes in breast cancer

Journal Articles

Abstract P5-12-02: Intratumor heterogeneity, angiogenesis and epithelial to mesenchymal transition are enhanced in metaplastic breast cancer

Masanori Oshi, Konstantinos Chouliaras, Mariko Asaoka, Rongrong Wu, Akimitsu Yamada, Thaer Khoury, Itaru Endo, Takashi Ishikawa, Kazuaki Takabe

Cancer Res (2022) 82 (4_Supplement): P5-12-02.

https://doi.org/10.1158/1538-7445.SABCS21-P5-12-02

Published: 15 February 2022

View article titled, Abstract P5-12-02: Intratumor heterogeneity, angiogenesis and epithelial to mesenchymal transition are enhanced in metaplastic breast cancer

Journal Articles

Abstract PS8-37: A breast cancer risk self-assessment model for Japanese women

Michiyo Yamada, Takashi Ishikawa, Sadatoshi Sugae, Kazutaka Narui, Peter Tonellato, Itaru Endo, Takashi Chishima

Cancer Res (2021) 81 (4_Supplement): PS8-37.

https://doi.org/10.1158/1538-7445.SABCS20-PS8-37

Published: 15 February 2021

View article titled, Abstract PS8-37: A breast cancer risk self-assessment model for Japanese women

Journal Articles

Abstract 296: BRCA1 degradation in response to mitochondrial damage in breast cancer cells

Kana Miyahara, Naoharu Takano, Yumiko Yamada, Hiromi Kazama, Mayumi Tokuhisa, Hirotsugu Hino, Koji Fujita, Edward Barroga, Masaki Hiramoto, Hiroshi Handa, Masahiko Kuroda, Takashi Ishikawa, Keisuke Miyazawa

Cancer Res (2020) 80 (16_Supplement): 296.

https://doi.org/10.1158/1538-7445.AM2020-296

Published: 15 August 2020

View article titled, Abstract 296: BRCA1 degradation in response to mitochondrial damage in breast cancer cells

NARROW

Abstract 2032: Intratumoral tumor infiltrating lymphocytes is associated with cell proliferation and better survival but not with response to chemotherapy

Abstract 1408: Increased infiltrating class-switched memory B cell in breast cancer tumors were associated with favorable prognostic outcome

Abstract PD2-10: MiR-150 expression in breast cancer cells attract infiltration of lymphocytes to tumor microenvironment and is associated with better survival of the patients

Abstract P2-20-12: Abundance of tumor-infiltrating lymphocytes is associated with pathologic complete response to neoadjuvant chemotherapy but not with survival in ER-positive/HER2-negative breast cancer

Abstract P3-05-33: High expression of MiR-99b in breast cancer is associated with cell proliferation signaling and worse patient survivals in breast cancer

Abstract P2-23-13: Highly proliferative estrogen receptor-positive breast cancer is associated with better response to neoadjuvant chemotherapy but worse clinical outcome

Abstract 812: High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer

Abstract 3061: Elevated bile acid metabolism is associated with breast cancer microbiome, less cell proliferation, and better survival

Abstract 5663: Clinical relevance of unfolded protein response (UPR) signaling in breast cancer

Abstract P3-10-01: Mir-150 expression is associated with immune cell infiltration and immune response in breast cancer

Abstract P1-01-15: Clinical relevance of TRIM37 gene expression in breast cancer

Abstract P1-05-06: Establishment of novel BRCA1ness score to quantify BRCAness in breast cancer

Abstract P3-19-27: Prognostic impact of postmastectomy radiation therapy in breast cancer patients with T1, 2 and 1-3 lymph nodes from Japan Breast Cancer Registry

Abstract P4-04-04: APOBEC3F is expressed by immune cells and is associated with immune response and survival in triple negative breast cancer

Abstract P4-07-29: Reactive Oxygen Species (ROS) pathway is associated with aggressive cancer biology, elevated immune response, and with worse survival in ER-positive/HER2-negative breast cancer

Abstract P5-06-03: Intratumoral lymphatic endothelial cell infiltration reflects lymphangiogenesis and lymph node metastasis, but is counterbalanced by immune response and better cancer biology in breast cancer tumor microenvironment

Abstract P5-03-01: Conflicting roles of EGFR expression by subtypes in breast cancer

Abstract P5-12-02: Intratumor heterogeneity, angiogenesis and epithelial to mesenchymal transition are enhanced in metaplastic breast cancer

Abstract PS8-37: A breast cancer risk self-assessment model for Japanese women

Abstract 296: BRCA1 degradation in response to mitochondrial damage in breast cancer cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only